Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
20.88
+1.03 (5.19%)
At close: Jun 26, 2026, 4:00 PM EDT
20.42
-0.46 (-2.20%)
After-hours: Jun 26, 2026, 7:28 PM EDT

Company Description

Doximity, Inc. operates a digital platform for medical professionals in the United States.

Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems.

The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool.

The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.

The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.

Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Doximity, Inc.
Doximity logo
Country United States
Founded 2010
IPO Date Jun 24, 2021
Industry Health Information Services
Sector Healthcare
Employees 880
CEO Jeffrey Tangney

Contact Details

Address:
500 3rd Street, Suite 510
San Francisco, California 94107
United States
Phone 650 549 4330
Website doximity.com

Stock Details

Ticker Symbol DOCS
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year April - March
Reporting Currency USD
IPO Price $26.00
CIK Code 0001516513
CUSIP Number 26622P107
ISIN Number US26622P1075
Employer ID 27-2485512
SIC Code 7371

Key Executives

Name Position
Jeffrey A. Tangney Co-Founder, Chief Executive Officer and Chairperson
Dr. Steven L. Zatz M.D. President
Matthew Sonefeldt Chief Financial Officer
Siddharth Sitaram Chief Accounting Officer and Interim Principal Financial and Accounting Officer
Jey Balachandran Chief Technology Officer
Perry Scott Gold Head of Investor Relations
John Vaughan General Counsel, Corporate Secretary and Chief Compliance Officer
Bruno Miranda Senior Vice President of Engineering
Joel Davis Senior Vice President of Product
Ben Greenberg Senior Vice President and GM Commercial Products

Latest SEC Filings

Date Type Title
Jun 9, 2026 144 Filing
Jun 8, 2026 144 Filing
May 19, 2026 S-8 Securities to be offered to employees in employee benefit plans
May 19, 2026 10-K Annual Report
May 15, 2026 SCHEDULE 13G/A Filing
May 13, 2026 8-K Current Report
May 11, 2026 144 Filing
May 7, 2026 144 Filing
Apr 29, 2026 SCHEDULE 13G Filing
Apr 17, 2026 8-K Current Report